GoKawiil
Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism?
(feeds.feedburner.com)
1.
2.
GLP-1 Users Are Being Cruelly Shamed by Their Own Families
(futurism.com)
3.
Daily briefing: GLP-1 obesity drugs slow signs of ageing in mice
(feeds.nature.com)
4.
Can GLP-1 drugs slow ageing? Mouse study shows promise
(feeds.nature.com)
6.
Ozempic may have a scary effect on your hair
(feeds.feedburner.com)
7.
GLP-1 drugs led to weight loss and reversed depression-like behavior in mice
(news.ycombinator.com)
8.
GLP-1 Drugs Appear to Prevent Cancer, New Research Finds
(futurism.com)
10.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
11.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
13.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
14.
15.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
16.
FDA Approves Eli Lilly’s GLP-1 Pill
(wired.com)
17.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
18.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
19.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
20.
21.
FDA approves higher-dose version of Wegovy shots
(feeds.feedburner.com)
22.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
23.
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here’s why
(feeds.feedburner.com)
24.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)